467219-97-2

Upstream product

• 467219-92-7 (1R,5S,7S)-4-Benzyloxymethyl-7-methoxymethoxy-bicyclo[3.2.1]oct-3-en-2-one 
• 467219-91-6 (1S,2R,5S,6S)-2-Benzyloxymethyl-6-methoxymethoxy-bicyclo[3.2.1]oct-3-en-2-ol 
• 351033-77-7 (1S,5S,6S)-6-Methoxymethoxy-bicyclo[3.2.1]oct-3-en-2-one 
• 66222-28-4 (benzyloxymethyl)tributylstannane 
• 467219-93-8 (1R,4R,5S,7S)-4-Benzyloxymethyl-7-methoxymethoxy-4-vinyl-bicyclo[3.2.1]octan-2-one 

Downstream Products

• 467220-03-7 Trifluoro-acetic acid (1S,4R,5R)-5-benzyloxymethyl-4-methoxycarbonylmethyl-5-vinyl-cyclohex-2-enyl ester 
• 467219-99-4 ((1S,2R)-2-Benzyloxymethyl-4-oxo-2-vinyl-cyclohexyl)-acetic acid methyl ester 
• 467220-01-5 ((1R,4S,6R)-6-Benzyloxymethyl-4-hydroxy-6-vinyl-cyclohex-2-enyl)-acetic acid methyl ester 
• 467220-00-4 ((1R,6R)-6-Benzyloxymethyl-4-oxo-6-vinyl-cyclohex-2-enyl)-acetic acid methyl ester 
• 467219-98-3 (1R,4R,5S)-4-Benzyloxymethyl-4-vinyl-bicyclo[3.2.1]octane-2,7-dione 

Relevant academic research and scientific papers

A concise route to the key intermediate of (+)-vernolepin using a bicyclo[3.2.1]octane Chiral building block

An enantioselective route to the key intermediate leading to (+)-vernolepin, an antitumor sesquiterpene, isolated from Vernonia hymenolepis, has been developed starting from the chiral building block having a bicyclo[3.2.1]octane framework accessible by either enzymatic or catalytic kinetic resolution.